Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2002, p. 1071-1072, Vol. 40, No. 3
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.3.1071-1072.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Doris J. Baker,1 and Jeffrey L. Winters2,
Department of Clinical Sciences,1 Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, Kentucky 40536-02982
Received 17 August 2001/ Returned for modification 11 November 2001/ Accepted 22 December 2001
Two companies, MRL and Meridian Diagnostics, have developed Food and Drug Administration-approved herpes simplex virus type 1 type-specific enzyme immunoassays. The sensitivity, specificity, and overall testing efficiency of these assays were 98.2, 93.8, and 96.6% for MRL and 98.8, 99.0, and 98.1% for Meridian, making both of these kits suitable for use in the clinical lab.
Present address: Boston I. V. F., Waltham, MA 02451.
Present address: The Mayo Clinic, Rochester, MN 55905.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|